DAAs Less Likely for Hep C Patients With Alcohol Use Disorder
Those with current alcohol use disorder or abstinent with alcohol use disorder history had lower likelihood of receiving direct-acting antivirals
Diagnosis & Disease Information
Hepatitis C Guideline Updated for Chronic Kidney Disease Population
The update reflects advances in hepatitis C management, such as antiviral therapy, increased use of hepatitis C kidney grafts, and treatment of glomerular diseases associated with the virus.
Lonafarnib-Based Regimens Look Promising for Patients With Chronic HDV Infection
The all-oral and combination treatment arms demonstrated statistically significant composite responses of 10.1% and 19.2%, respectively.
Bepirovirsen Studied for Treatment of Chronic Hepatitis B Infection
Dosage regimens for bepirovirsen explored in phase 2b, randomized, investigator-unblinded trial
Vemlidy Approved for Pediatric Patients With Chronic HBV Infection
The approval was supported by data from a phase 2 trial that included 70 patients aged 12 to less than 18 years with chronic HBV infection.
Monkeypox MVA-BN Vaccine Elicits Durable Immunity for 2 Years With Single Dose
The MVA-BN vaccine, developed by Bavarian Nordic, was evaluated in a clinical trial.
Elevated ALT Following Hepatitis C Treatment May Indicate Treatment Failure
Any increase in ALT following treatment completion was found to be associated with treatment failure.
Few Insured Individuals Receive Timely DAA Treatment for Hep C
Individuals with Medicare and Medicaid have lower odds of treatment initiation than those with private insurance
Two Case Series Describe Acute Pediatric Hepatitis of Unknown Cause
Unclear whether human adenovirus is the causative agent for acute hepatitis in these children
